Explore our Website
The Knowledgebase is an online resource where you can search for information about allergy.
Around one third of the UK population (approximately 19 million people) will develop an allergy at some time in their lives.
Join us as a member of the Anaphylaxis Campaign today and help us to raise the profile of severe allergy and support those who live with life threatening allergies.
Topics of Interest
We have developed a comprehensive guide for employees and employers to help people with severe allergies at work, including an adult allergy action plan. Read more…
Our Support Groups are organised by our friendly volunteers, and are the perfect chance to meet other people living with severe allergies in your local area. Read more…
Every school is likely to have at least one pupil who is severely allergic to a type of food, and many schools will have more. Read more…
Please donate today to help us provide free services for people in need of advice and support
8th April 2021
As the Covid-19 vaccine roll-out continues apace in the UK, increasingly publicity has been given to the proposal that some form of certificate or ‘passport’ may be implemented, linked to the identity of the holder, to verify vaccination status and allow access to public venues, large gatherings, travel and other public arenas thereby, in theory, […]
6th April 2021
On the 23rd and 24th March, the Food Standards Agency (FSA) held their second annual Food Hypersensitivity Symposium which brought together delegates from a variety of backgrounds including food business operators, local authority enforcement, clinical allergy specialists and allergy patient organisations. The Anaphylaxis Campaign was delighted to attend and to contribute to the interactive workshops […]
JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine
29th March 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised the government to prioritise people for the coronavirus (COVID-19) vaccine who are over 16 and living with adults who have weakened immune systems, such as those with blood cancer, HIV or those on immunosuppressive treatment including chemotherapy. Adults who are immunosuppressed have a weaker immune […]
10th March 2021
Camallergy (Cambridge Allergy Ltd) a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, has announced it’s been awarded £1.1M funding under the Innovate UK Biomedical Catalyst Award program administered by Innovate UK, the United Kingdom’s research and innovation agency. It is hoped that the funding will accelerate the development of the peanut […]